HomeTagsExcyte Biopharma Ltd

Tag: Excyte Biopharma Ltd

spot_imgspot_img
Medical

First patient dosed in YK012 trial-the world’s first TCE therapy for primary membranous nephropathy

Key Highlights - Clinical trial to evaluate the safety and efficacy of YK012 in primary membranous nephropathy - Globally, this is the first bispecific CD19-directed CD3...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read

spot_img